Acute and long-term effects of electroconvulsive therapy on human dentate gyrus.


Journal

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology
ISSN: 1740-634X
Titre abrégé: Neuropsychopharmacology
Pays: England
ID NLM: 8904907

Informations de publication

Date de publication:
09 2019
Historique:
received: 24 07 2018
accepted: 30 12 2018
revised: 27 12 2018
pubmed: 10 1 2019
medline: 17 3 2020
entrez: 10 1 2019
Statut: ppublish

Résumé

Electroconvulsive therapy (ECT) is the most effective treatment for severe depression, although the underlying mechanisms remain unclear. Animal studies have consistently shown that electroconvulsive stimulation induces neuroplastic changes in the dentate gyrus. To date, few studies have investigated the effect of ECT on human hippocampal subfields. In the current study, structural magnetic resonance imaging (MRI) was conducted in 25 patients with major depressive episodes at 3 time points: before ECT (TP1), after 1 week of the last ECT (TP2) and after 3 months of the last ECT (TP3). Twenty healthy controls were scanned twice with an interval similar to patients between TP1 and TP2. Volumetric analyses of the cornu ammonis (CA)4/dentate gyrus (DG) were performed using the MAGeT-Brain (Multiple Automatically Generated Templates) algorithm. Clinically remitted patients after ECT showed larger volume increases in the right CA4/DG than non-remitted patients. Volume increases in the right CA4/DG were negatively associated with age. Increased CA4/DG volumes after ECT returned to baseline levels after 3 months irrespective of clinical state. ECT-induced volume increase in the CA4/DG was associated with age and clinical remission. These findings are consistent with the neurotrophic processes seen in preclinical studies. Neuroplastic change in the CA4/DG might mediate some of the short-term antidepressant effects of ECT.

Identifiants

pubmed: 30622299
doi: 10.1038/s41386-019-0312-0
pii: 10.1038/s41386-019-0312-0
pmc: PMC6785137
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1805-1811

Références

Kellner CH, Greenberg RM, Murrough JW, Bryson EO, Briggs MC, Pasculli RM. ECT in treatment-resistant depression. Am J Psychiatry. 2012;169:1238–44.
doi: 10.1176/appi.ajp.2012.12050648
Dierckx B, Heijnen WT, van den Broek WW, Birkenhager TK. Efficacy of electroconvulsive therapy in bipolar versus unipolar major depression: a meta-analysis. Bipolar Disord. 2012;14:146–50.
doi: 10.1111/j.1399-5618.2012.00997.x
Kellner CH, Fink M, Knapp R, Petrides G, Husain M, Rummans T, et al. Relief of expressed suicidal intent by ECT: a consortium for research in ECT study. Am J Psychiatry. 2005;162:977–82.
doi: 10.1176/appi.ajp.162.5.977
Madsen TM, Treschow A, Bengzon J, Bolwig TG, Lindvall O, Tingstrom A. Increased neurogenesis in a model of electroconvulsive therapy. Biol Psychiatry. 2000;15:1043–9.
doi: 10.1016/S0006-3223(00)00228-6
Perera TD, Coplan JD, Lisanby SH, Lipira CM, Arif M, Carpio C, et al. Antidepressant-induced neurogenesis in the hippocampus of adult nonhuman primates. J Neurosci. 2007;27:4894–901.
doi: 10.1523/JNEUROSCI.0237-07.2007
Bouckaert F, Sienaert P, Obbels J, Dols A, Vandenbulcke M, Stek M, et al. ECT: it’s brain enabling effects: a review of electroconvulsive therapy-induced structural brain plasticity. J ECT. 2014;30:143–51.
doi: 10.1097/YCT.0000000000000129
Wennström M, Hellsten J, Ekstrand J, Lindgren H, Tingström A. Corticosterone-induced inhibition of gliogenesis in rat hippocampus is counteracted by electroconvulsive seizures. Biol Psychiatry. 2006;59:178–86.
doi: 10.1016/j.biopsych.2005.08.032
Chen F, Madsen TM, Wegener G, Nyengaard JR. Repeated electroconvulsive seizures increase the total number of synapses in adult male rat hippocampus. Eur Neuropsychopharmacol. 2009;19:329–38.
doi: 10.1016/j.euroneuro.2008.12.007
Kaae SS, Chen F, Wegener G, Madsen TM, Nyengaard JR. Quantitative hippocampal structural changes following electroconvulsive seizure treatment in a rat model of depression. Synapse. 2012;66:667–76.
doi: 10.1002/syn.21553
Schloesser RJ, Orvoen S, Jimenez DV, Hardy NF, Maynard KR, et al. Antidepressant-like effects of electroconvulsive seizures require adult neurogenesis in a neuroendocrine model of depression. Brain Stimul. 2015;8:862–7.
doi: 10.1016/j.brs.2015.05.011
Takamiya A, Chung JK, Liang KC, Graff-Guerrero A, Mimura M, Kishimoto T. Effect of electroconvulsive therapy on hippocampal and amygdala volumes: systematic review and meta-analysis. Br J Psychiatry. 2018;212:19–26.
doi: 10.1192/bjp.2017.11
Cao B, Passos IC, Mwangi B, Amaral-Silva H, Tannous J, Wu MJ, et al. Hippocampal subfield volumes in mood disorders. Mol Psychiatry. 2017;22:1352–8.
doi: 10.1038/mp.2016.262
Abbott CC, Jones T, Lemke NT, Gallegos P, McClintock SM, Mayer AR, et al. Hippocampal structural and functional changes associated with electroconvulsive therapy response. Transl Psychiatry. 2014;4:e483.
doi: 10.1038/tp.2014.124
Cao B, Luo Q, Fu Y, Du L, Qiu T, Yang X, et al. Predicting individual responses to the electroconvulsive therapy with hippocampal subfield volumes in major depression disorder. Sci Rep. 2018;8:5434.
doi: 10.1038/s41598-018-23685-9
Semkovska M, McLoughlin DM. Objective cognitive performance associated with electroconvulsive therapy for depression: a systematic review and meta-analysis. Biol Psychiatry. 2010;68:568–77.
doi: 10.1016/j.biopsych.2010.06.009
Pipitone J, Park MTM, Winterburn J, Lett TA, Lerch JP, Pruessner JC, et al. Multi-atlas segmentation of the whole hippocampus and subfields using multiple automatically generated templates. Neuroimage. 2014;101:494–512.
doi: 10.1016/j.neuroimage.2014.04.054
Chakravarty MM, Steadman P, van Eede MC, Calcott RD, Gu V, Shaw P, et al. Performing label-fusion-based segmentation using multiple automatically generated templates. Hum Brain Mapp. 2013;34:2635–54.
doi: 10.1002/hbm.22092
Plitman E, Patel R, Chung JK, Pipitone J, Chavez S, Reyes-Madrigal F, et al. Glutamatergic metabolites, volume and cortical thickness in antipsychotic-naïve patients with first-episode psychosis: implications for excitotoxicity. Neuropsychopharmacology. 2016;41:2606–13.
doi: 10.1038/npp.2016.84
Bouckaert F, Dols A, Emsell L, De Winter F-L, Vansteelandt K, Claes L, et al. Relationship between hippocampal volume, serum bdnf and depression severity following electroconvulsive therapy in late-life depression. Neuropsychopharmacology. 2016;41:2741–8.
doi: 10.1038/npp.2016.86
Santarelli L, Saxe M, Gross C, Surget A, Battaglia F, Dulawa S, et al. Requirement of hippocampal effects of antidepressants. Science. 2003;805:805–9.
doi: 10.1126/science.1083328
Malberg J, Eisch A, Nestler EJ, Suman RS. Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus. J Neurosci. 2000;20:9104–10.
doi: 10.1523/JNEUROSCI.20-24-09104.2000
Eriksson PS, Perfilieva E, Bjork-Eriksson T, Alborn AM, Nordborg C, Peterson DA, et al. Neurogenesis in the adult human hippocampus. Nat Med. 1998;4:1313–8.
doi: 10.1038/3305
Spalding KL, Bergmann O, Alkass K, Bernard S, Salehpour M, Huttner HB, et al. Dynamics of hippocampal neurogenesis in adult humans. Cell. 2013;153:1219–27.
doi: 10.1016/j.cell.2013.05.002
Sorrells SF, Pareded MF, Cebrian-Silla A, Sandovai K, Qi D, Kelley KW, et al. Human hippocampal neurogeneis drops sharply in children to undetectable levels in adults. Nature. 2018;555:377–81.
doi: 10.1038/nature25975
Chakravarty MM, Hamani C, Martinez-Canabal A, Ellegood J, Laliberte C, Nobrega JN, et al. Deep brain stimulation of the ventromedial prefrontal cortex causes reorganization of neuronal processes and vasculature. Neuroimage. 2016;125:422–7.
doi: 10.1016/j.neuroimage.2015.10.049
Rotheneichner P, Lange S, O’Sullivan A, Marschallinger J, Zaunmair P, Geretsegger C et al. Hippocampal neurogenesis and antidepressive therapy: Shocking relations. Neural Plast. 2014: 723915:14p.
Boldrini M, Fulmore CA, Tartt AN, Simeon LR, Pavlova V, Rosoklija GB, et al. Human hippocampal neurogenesis persists throughout aging. Cell Stem Cell. 2018;22:589–99.
doi: 10.1016/j.stem.2018.03.015
Chang AD, Vaidya PV, Retzbach EP, Chung SJ, Kim U, Baselice K, et al. Narp mediates antidepressant-like effects of electroconvulsive seizures. Neuropsychopharmacology. 2018;43:1088–98.
doi: 10.1038/npp.2017.252
Bessa JM, Ferreria D, Melo I, Marques F, Cerqueira JJ, Palha JA, et al. The mood-improving actions of antidepressants do not depend on neurogenesis but are associated with neuronal remodeling. Mol Psychiatry. 2009;4:764–73.
doi: 10.1038/mp.2008.119
Samuels BA, Hen R. Neurogenesis and affective disorders. Eur J Neurosci. 2011;33:1152–9.
doi: 10.1111/j.1460-9568.2011.07614.x
Fava M, Johe K, Ereshefsky L, Gertsik LG, English BA, Biello JA, et al. A phase 1B, randomized, double blind, placebo controlled, multiple-dose escalation study of NSI-189 phosphate, a neurogenic compound, in depressed patients. Mol Psychiatry. 2016;21:1372–80.
doi: 10.1038/mp.2015.178
van Diermen L, van den Ameele S, Kamperman AM, Sabbe BCG, Vermeulen T, Schrijvers D, et al. Prediction of electroconvulsive therapy response and remission in major depression: meta-analysis. Br J Psychiatry. 2018;212:71–80.
doi: 10.1192/bjp.2017.28
Sartorius A, Demirakca T, Bohringer A, Clemm von Hohenberg C, Aksay SS, Bumb JM et al. Electroconvulsive therapy induced gray matter increase is not necessarily correlated with clinical data in depressed patients. Brain Stimul. 2018;S1935-861:30418-2.
Hyett MP, Breakspear MJ, Friston KJ, Guo CC, Parker GB. Disrupted effective connectivity of cortical systems supporting attention and interoception in melancholia. JAMA Psychiatry. 2015;72:350–8.
doi: 10.1001/jamapsychiatry.2014.2490
Parker G, Fink M, Shorter E, Taylor MA, Akiskal H, Berrios G, et al. Issues for DSM-5: whither melancholia? The case for its classification as a distinct mood disorder. Am J Psychiatry. 2015;167:745–7.
doi: 10.1176/appi.ajp.2010.09101525
Bolwig TG and Madsen TM. Electroconvulsive therapy in melancholia: the role of hippocampal neurogenesis. Acta Psychiatr Scand Suppl. 2007;115:130–5.
doi: 10.1111/j.1600-0447.2007.00971.x
Rasmussen KG. Electroconvulsive therapy and melancholia: review of the literature and suggestions for further study. J ECT. 2011;27:315–22.
doi: 10.1097/YCT.0b013e31820a9482
van Oostrom I, van Eijndhoven P, Butterbrod E, van Beek MH, Janzing J, Donders R, et al. Decreased cognitive functioning after electroconvulsive therapy is related to increased hippocampal volume: exploring the role of brain plasticity. J ECT. 2018;34:117–23.
doi: 10.1097/YCT.0000000000000483
Nordanskog P, Larson MR, Larsson EM, Johanson A. Hippocampal volume in relation to clinical and cognitive outcome after electroconvulsive therapy in depression. Acta Psychiatr Scand. 2014;129:303–11.
doi: 10.1111/acps.12150
Nordanskog P, Dahlstrand U, Larsson MR, Larsson E-M, Knutsson L, Johanson A. Increase in hippocampal volume after electroconvulsive therapy in patients with depression: a volumetric magnetic resonance imaging study. J ECT. 2010;26:62–67.
doi: 10.1097/YCT.0b013e3181a95da8
Jorgensen A, Magnusson P, Hanson LG, Kirkegaard T, Benveniste H, Lee H, et al. Regional brain volumes, diffusivity, and metabolite changes after electroconvulsive therapy for severe depression. Acta Psychiatr Scand. 2016;133:154–64.
doi: 10.1111/acps.12462
Kunigiri G, Jayakumar PN, Janakiramaiah N, Gangadhar BN. MRI T(2) relaxometry of brain regions and cognitive dysfunction following electroconvulsive therapy. Indian J Psychiatry. 2007;49:195–9.
doi: 10.4103/0019-5545.37321
Szabo K, Hirsch JG, Krause M, Ende G, Henn FA, Sartorius A, et al. Diffusion weighed MRI in the early phase after electroconvulsive therapy. Neurol Res. 2007;29:256–9.
doi: 10.1179/174313206X153842
Franklin TR, Wag Z, Shin J, Jagannathan K, Suh JJ, Detre JA, et al. A VBM study demonstrating ‘apparant’ effects of a single dose of medication on T1-weighted MRIs. Brain Struct Funct. 2013;218:97–104.
doi: 10.1007/s00429-012-0385-6
Oltedal L, Narr KL, Abbott C, Anand A, Argyelan M, Bartsch H, et al. Volume of the human hippocampus and clinical response following electroconvulsive therapy. Biol Psychiatry. 2018;41:105–14.
Joshi SH, Espinoza RT, Pirnia T, Shi J, Wang Y, Ayers B, et al. Structural plasticity of the hippocampus and amygdala induced by electroconvulsive therapy in major depression. Biol Psychiatry. 2016;79:282–92.
doi: 10.1016/j.biopsych.2015.02.029
Sheline YI, Pieper CF, Barch DM, Welsh-Bohmer K, McKinstry RC, MacFall JR, et al. Support for the vascular depression hypothesis in late-life depression: results of a 2-site, prospective, antidepressant treatment trial. Arch Gen Psychiatry. 2010;67:277–85.
doi: 10.1001/archgenpsychiatry.2009.204
De Winter FL, Emsell L, Bouckaert F, Claes L, Jain S, Farrar G, et al. No association of lower hippocampal volume with Alzheimer’s disease pathology in late-life depression. Am J Psychiatry. 2017;174:237–45.
doi: 10.1176/appi.ajp.2016.16030319
Olesen MV, Wortwein G, Folke J, Pakkenberg B. Electroconvulsive stimulation results in long-term survival of newly generated hippocampal neurons in rats. Hippocampus. 2017;27:52–60.
doi: 10.1002/hipo.22670
Nordgren M, Karlsson T, Svensson M, Koczy J, Josephson A, Olson L, et al. Orchestrated regulation of Nogo receptors, LOTUS, AMPA receptor and BDNF in an ECT model suggests opening and closure of a window of synaptic plasticity. PLoS ONE. 2013;8:e78778.
doi: 10.1371/journal.pone.0078778

Auteurs

Akihiro Takamiya (A)

Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, 160-8582, Japan.
Center for Psychiatry and Behavioral Science, Komagino Hospital, Tokyo, 193-8505, Japan.

Eric Plitman (E)

Cerebral Imaging Center, Douglas Mental Health University Institute, Quebec, Montreal, H4H 1R3, Canada.
Department of Biological and Biomedical Engineering, McGill University, Quebec, Montreal, H3A 0G4, Canada.

Jun Ku Chung (JK)

Institute of Medical Science, Faculty of Medicine, University of Toronto, Toronto, M5S 1A8, Canada.
Multimodal Imaging Group - Research Imaging Centre, Centre for Addiction and Mental Health, Toronto, M6J 1H4, Canada.

Mallar Chakravarty (M)

Cerebral Imaging Center, Douglas Mental Health University Institute, Quebec, Montreal, H4H 1R3, Canada.
Department of Biological and Biomedical Engineering, McGill University, Quebec, Montreal, H3A 0G4, Canada.

Ariel Graff-Guerrero (A)

Institute of Medical Science, Faculty of Medicine, University of Toronto, Toronto, M5S 1A8, Canada.
Multimodal Imaging Group - Research Imaging Centre, Centre for Addiction and Mental Health, Toronto, M6J 1H4, Canada.
Department of Psychiatry, University of Toronto, Toronto, M5T 1R8, Canada.
Geriatric Mental Health Division, Centre for Addiction and Mental Health, Toronto, M6J 1H4, Canada.

Masaru Mimura (M)

Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, 160-8582, Japan.

Taishiro Kishimoto (T)

Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, 160-8582, Japan. tkishimoto@keio.jp.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH